Ask the expert: should you get the shingles vaccine?

Asked By: Lowell Hill
Date created: Fri, Jul 16, 2021 12:37 PM
Best answers
Answered By: Elvera Schmidt
Date created: Fri, Jul 16, 2021 5:05 PM
You should get the vaccine, definitely, if you are over 60. Since the shingles vaccine is relatively new, how long the vaccine lasts is a question that's still being studied. At this point we know the vaccine provides 5 years of protection at the very least, but it's possible that you would only need to get it once in your life.
Answered By: Nelle Blick
Date created: Sat, Jul 17, 2021 1:55 AM
In its 2018 zoster vaccine recommendations, the Advisory Committee on Immunization Practices (ACIP) states that Shingrix may be used in adults age 50 years or older irrespective of prior receipt of varicella vaccine or live zoster vaccine (Zostavax).
Answered By: Harvey Stamm
Date created: Sat, Jul 17, 2021 2:30 AM
If I've already had shingles, should I get the vaccine so that I don't get shingles again? People looking to receive the shingles vaccine now have two options. The Food and Drug Administration in 2017 approved Shingrix. It's the preferred alternative to Zostavax, which was approved in 2006. Both vaccines are approved for adults age 50 and older for the prevention of shingles and related complications, whether they've already had shingles or not. You may get the Shingrix vaccine even if you ...
Answered By: Barry Schmidt
Date created: Sat, Jul 17, 2021 6:18 AM
In addition, you should get the Shingrix vaccine even if you already got the Zostavax vaccine — although you should wait at least eight weeks from the time you received Zostavax to get the Shingrix shot. Coronavirus COVID-19 Resource Center While the COVID-19 pandemic continues to rage in parts of the world, it is slowly retreating in the U.S.
Answered By: Jillian Effertz
Date created: Sat, Jul 17, 2021 9:12 AM
CDC recommends that healthy adults 50 years and older get two doses of the shingles vaccine called Shingrix (recombinant zoster vaccine), separated by 2 to 6 months, to prevent shingles and the complications from the disease. Your doctor or pharmacist can give you Shingrix as a shot in your upper arm.
Answered By: Lavern Rath
Date created: Sat, Jul 17, 2021 10:52 AM
If you’re 50 or older and healthy, there are two things experts think you should know: You’re almost certainly as risk of getting shingles, and you should get vaccinated.
Answered By: Elmore Dicki
Date created: Sat, Jul 17, 2021 8:51 PM
You should give a dose of varicella vaccine now since it has been more than 4 weeks since the dose of live zoster vaccine. The varicella vaccine dose may not be needed, but it will not be harmful and will allow your patient to meet the regulatory requirement. Note that if the vaccine she received was recombinant zoster vaccine (RZV, Shingrix, GlaxoSmithKline) it does NOT count as the first of two doses of varicella vaccine.
Answered By: Napoleon Wilderman
Date created: Sat, Jul 17, 2021 11:34 PM
Ask the Expert Anti-IL5 therapy and Herpes zoster Anti-IL5 therapy and Herpes zoster. Question: 8/14/2018 As I am starting to use more Nucala and Fasenra, I am interested to know your approach to discussing the risk of Herpes Zoster with patients. For patients over 50, I recommend the Zoster vaccine if they have not received it. Do you recommend that patients younger than 50 get the Zoster Vaccine if they are starting Nucala or Fasenra? Also, do you feel like it is OK to give the zoster ...
Answered By: Kaylah Connelly
Date created: Sun, Jul 18, 2021 9:50 AM
Experts Answer Questions About Vaccines. New and updated Ask the Experts questions are emailed to IAC Express subscribers 5 times per year. Join more than 50,000 subscribers to IAC Express. It's free. If you have a question that you think may be of interest to our readers, please send it to us using our online form.
Answered By: Lamar Mraz
Date created: Sun, Jul 18, 2021 7:11 PM
The ACIP recommends that routine HPV vaccination be initiated for all children at age 11 or 12 years. Vaccination can be started as early as age 9 years. Vaccination is also recommended for all people age 13 through 26 years who have not been vaccinated previously or who have not completed the vaccination series.
FAQ
❓😷

Use biontech vaccine in the belarus 2020?

🏥
Updated 25 June 2021, pursuant to updated interim recommendations . WHO’s Strategic Advisory Group of Experts on Immunization (SAGE) has issued its policy recommendations for the rollout of the first COVID-19 vaccine approved for emergency use, the Pfizer-BioNTech COVID-19 vaccine. According to SAGE, the Pfizer-BioNTech COVID-19 mRNA vaccine is safe and effective.

Use biontech vaccine in the belarus 2020?

❓😷

Use curevac vaccine in the albania?

🏥
CureVac initiates a Phase 2a clinical trial of its COVID-19 vaccine candidate in Peru and Panama. Early September 2020. CureVac receives a grant of up to 252 million euros from the German Federal Ministry of Education and Research to further its COVID-19 vaccine development and expand its production capacity.

http://ascoronavirus.com/use-curevac-vaccine-in-the-albania

❓😷

Use sinovac vaccine in the afghanistan?

🏥
The WHO Strategic Advisory Group of Experts (SAGE) on Immunization has issued Interim recommendations for the use of the inactivated COVID-19 vaccine, Sinovac-CoronaVac, developed by Sinovac/China National Pharmaceutical Group.. Here is what you need to know. This article provides a summary of the interim recommendations; the interim recommendations and the background document are also ...

Use sinovac vaccine in the afghanistan?

21 Related questions

We've handpicked 21 related questions for you, similar to «Ask the expert: should you get the shingles vaccine?» so you can surely find the answer!

Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine: The Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) recommended that use of (J&J/Janssen) COVID-19 Vaccine resume in the United States, effective April 23, 2021. However, women younger than 50 years old should especially be aware of the rare risk of blood clots with low platelets after...
CureVac has another chance to get back in the race. It is developing a second-generation vaccine in collaboration with GlaxoSmithKline, which appears to elicit 10 times more antibodies than its first.
How Well the Vaccine Works. Based on evidence from clinical trials in people 16 years and older, the Pfizer-BioNTech vaccine was 95% effective at preventing laboratory-confirmed infection with the virus that causes COVID-19 in people who received two doses and had no evidence of being previously infected.; In clinical trials, the Pfizer-BioNTech vaccine was also highly effective at preventing...
The available data on the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women are insufficient to assess either vaccine efficacy or possible vaccine-associated risks in pregnancy. However, this vaccine is an inactivated vaccine with an adjuvant that is commonly used in many other vaccines with a well-documented safety profile, such as Hepatitis B and Tetanus vaccines, including in pregnant...
Novavax is much more similar to traditional vaccines even though it uses new technology. Therefore, I believe that many of the vaccine hesitant will be willing to take it. You should feel...
Tue 1 Jun 2021 20.01 EDT. The World Health Organization has approved the Sinovac Covid-19 vaccine for emergency use – the second Chinese vaccine to receive the WHO’s green light. The UN health...
How Well the Vaccine Works. Based on evidence from clinical trials, in people aged 18 years and older, the Moderna vaccine was 94.1% effective at preventing laboratory-confirmed COVID-19 infection in people who received two doses and had no evidence of being previously infected.; The vaccine was also highly effective in clinical trials at preventing COVID-19 among people of diverse age, sex...
CureVac COVID-19 vaccine. The CureVac COVID-19 vaccine is a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). As of April 2021 it is currently in Phase III clinical trials. The manufacturer markets the vaccine under the name CVnCoV.
June 16, 2021. The German company CureVac delivered disappointing preliminary results on Wednesday from a clinical trial of its Covid-19 vaccine, dimming hopes that it could help fill the world...
Novavax is a vaccine company that, despite $2 billion in new federal and international funding, still hasn’t come through with a licensed covid vaccine. It hopes it can still help to fight th…
Moderna is the second drugmaker in the U.S. to begin applying for full FDA approval for its COVID-19 vaccine. Moderna's COVID-19 vaccine is currently authorized under an Emergency Use Authorization (EUA) for adults 18 and up. Last month, Pfizer and BioNTech announced they had started the approval process.
Novavax was 89.7% effective in preventing symptomatic COVID-19 infections. It was 86.3% effective against the alpha variant and 96.4% effective against other variants of the virus. The results are...
Novartis (NOVN.S) is still helping CureVac (5CV.DE) make COVID-19 vaccines and could expand its capacity to assist other vaccine manufacturers as well, finance chief Harry Kirsch told reporters on...
The Novavax vaccine uses a custom-made spike protein that mimics the natural spike protein in the SARS-CoV-2 virus. Novavax has for years worked on developing its recombinant nanoparticle technology, and created the first COVID-19 vaccine using this method in the spring of 2020. By summer 2020, early clinical trials showed that the vaccine...
Sputnik V (Russian: Спутник V) or Gam-COVID-Vac (Russian: Гам-КОВИД-Вак) is an adenovirus viral vector vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia.It is the world's first registered combination vector vaccine for the prevention of COVID-19, having been registered on 11 August 2020 by the Russian Ministry of Health.
The Novavax COVID-19 vaccine, codenamed NVX-CoV2373, is a subunit COVID-19 vaccine candidate developed by Novavax and the Coalition for Epidemic Preparedness Innovations (CEPI), that is undergoing trials in India under the brand name Covovax. It requires two doses and is stable at 2 to 8 °C (36 to 46 °F) refrigerated temperatures.
As of 19 April 2021, the AstraZeneca vaccine is safe and effective at protecting people from the extremely serious risks of COVID-19, including death, hospitalization and severe disease. Read the 16 April 2021 statement of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine, which covers reports of very rare side...
The available data on the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women are insufficient to assess either vaccine efficacy or possible vaccine-associated risks in pregnancy. However, this vaccine is an inactivated vaccine with an adjuvant that is commonly used in many other vaccines with a well-documented safety profile, such as Hepatitis B and Tetanus vaccines, including in pregnant women. The effectiveness of the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women is therefore...
CureVac COVID-19 vaccineINN: zorecimeran. The CureVac COVID-19 vaccine (abbreviated CVnCoV) is a COVID-19 vaccine candidate developed by CureVac N.V. and the Coalition for Epidemic Preparedness Innovations (CEPI). The vaccine showed inadequate results in its Phase III trials with only 47% efficacy. The European Medicines Agency stated that...
Novavax is an old fashioned type of vaccine. By Hilda Bastian. The hype around the early-bird vaccines from Pfizer and Moderna has distorted perception. Their rapid arrival has been described in this magazine as “the triumph of mRNA” -- a brand-new vaccine technology whose “potential stretches far beyond this pandemic.”...
How COVID-19 deaths are recorded may differ between countries (e.g., some countries may only count hospital deaths, whilst others also include deaths in homes). The death figures on a given date do not necessarily show the number of new deaths on that day, but the deaths reported on that day.